If you read our initial Benicar Lawsuit Settlement article, you know that Benicar reached a $300 million settlement a little over a year ago. Since then, we have learned that there are several drugs, containing the active ingredient olmesartan medoxomil, that were sold under different brand names. Those drugs include the following: Benicar — olmesartan
In August 2017, the manufacturer of hypertension drug Benicar announced a $300 million settlement to resolve about 2,300 claims in state and federal courts that the drug caused severe gastrointestinal injuries among patients. The suits involved Benicar and its sister drugs Azor and Tribenzor, all of which contain olmesartan as an active ingredient. The plaintiffs
